Triple-Class Virologic Failure in HIV-Infected Patients Undergoing Antiretroviral Therapy for Up to 10 Years | Zendy

Pursuing Later Treatment Options | Zendy; R Lodwick | Zendy; Dominique Costagliola | Zendy; Peter Reiß | Zendy; Carlo Torti | Zendy; Ramón Teira | Zendy; Maria Dorrucci | Zendy; Bruno Ledergerber | Zendy; Amanda Mocroft | Zendy; Daniel Podzamczer | Zendy; Alessandro Cozzi-Lepri | Zendy; Niels Obel | Zendy; Bernard Masquelier | Zendy; Schlomo Staszewski | Zendy; Féderico García | Zendy; Stéphane De Wit | Zendy; Antonella Castagna | Zendy; Andrea Antinori | Zendy; Ali Judd | Zendy; Jade Ghosn | Zendy; Giota Touloumi | Zendy; Cristina Mussini | Zendy; Xavier Duval | Zendy; José Manuel Ramos | Zendy; Laurence Meyer | Zendy; Josiane Warsawski | Zendy; Claire Thorne | Zendy; Joan Corominas Masip | Zendy; Santiago PérezHoyos | Zendy; Deenan Pillay | Zendy; Ard van Sighem | Zendy; Sergio Lo Caputo | Zendy; Huldrych F. Günthard | Zendy; Roger Paredes | Zendy; Andrea De Luca | Zendy; Dimitrios Paraskevis | Zendy; Céline Fabre-Colin | Zendy; Jesper Kjær | Zendy; Geneviève Chêne | Zendy; Jens Lundgren | Zendy; Andrew Phillips | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Triple-Class Virologic Failure in HIV-Infected Patients Undergoing Antiretroviral Therapy for Up to 10 Years

Author(s) -

Pursuing Later Treatment Options,

R Lodwick,

Dominique Costagliola,

Peter Reiß,

Carlo Torti,

Ramón Teira,

Maria Dorrucci,

Bruno Ledergerber,

Amanda Mocroft,

Daniel Podzamczer,

Alessandro Cozzi-Lepri,

Niels Obel,

Bernard Masquelier,

Schlomo Staszewski,

Féderico García,

Stéphane De Wit,

Antonella Castagna,

Andrea Antinori,

Ali Judd,

Jade Ghosn,

Giota Touloumi,

Cristina Mussini,

Xavier Duval,

José Manuel Ramos,

Laurence Meyer,

Josiane Warsawski,

Claire Thorne,

Joan Corominas Masip,

Santiago PérezHoyos,

Deenan Pillay,

Ard van Sighem,

Sergio Lo Caputo,

Huldrych F. Günthard,

Roger Paredes,

Andrea De Luca,

Dimitrios Paraskevis,

Céline Fabre-Colin,

Jesper Kjær,

Geneviève Chêne,

Jens Lundgren,

Andrew Phillips

Publication year - 2010

Publication title -

archives of internal medicine

Language(s) - English

Resource type - Journals

eISSN - 1538-3679

pISSN - 0003-9926

DOI - 10.1001/archinternmed.2009.472

Subject(s) - regimen , interquartile range , ritonavir , medicine , confidence interval , reverse transcriptase inhibitor , population , protease inhibitor (pharmacology) , lopinavir , antiretroviral therapy , observational study , viral load , human immunodeficiency virus (hiv) , virology , environmental health

Life expectancy of people with human immunodeficiency virus (HIV) is now estimated to approach that of the general population in some successfully treated subgroups. However, to attain these life expectancies, viral suppression must be maintained for decades.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research